Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Pruritus
NCT05287724Phase 1Completed
- Sponsor
- Wright State University
- Start
- Jun 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetylcysteine in pruritus (2 arms), sponsored by Wright State University. Primary endpoints: Change in pain level from baseline with NAC at 7 days, Change in pain level from baseline with placebo at 7 days and 2 more. Started Jun 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT05287724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05287724.